Involvement of α- and β-catenins and E-cadherin in the development of mammary phyllodes tumours

Histopathology. 2012 Oct;61(4):667-74. doi: 10.1111/j.1365-2559.2012.04271.x.

Abstract

Aims: Phyllodes tumours (PT) are rare but clinically important fibroepithelial tumours of the breast. β-Catenin, a key component in Wnt signalling, has been shown to be important in the development of PT. It also functions as a component of the cadherin complex, which may therefore be implicated in PT pathogenesis. By assessing stromal α-catenin, β-catenin and E-cadherin expression in 158 PT cases using immunohistochemistry and examining associations with clinicopathological features, we aimed to determine the role of these proteins in PT pathogenesis.

Methods and results: Cytoplasmic β-catenin correlated with α-catenin expression. A significantly higher expression of both markers was observed in borderline than in benign PT (P = 0.003 and <0.001, respectively), but a lower level was found in malignant PT. Cytoplasmic E-cadherin expression was significantly higher in borderline and malignant than in benign PT (P = 0.001 and 0.012, respectively), but was not correlated with other markers. Both E-cadherin and α-catenin showed stronger correlations with histological parameters than β-catenin. α-Catenin showed a significant correlation with recurrence (P = 0.005 and 0.016, respectively).

Conclusion: α- and β-catenins may be important in the early stages of PT development, while E-cadherin may be required for malignant development. The correlation of α-catenin expression with tumour recurrence may be relevant in predicting PT behaviour.

Keywords: E-cadherin; phyllodes tumour; α-catenin; β-catenin.

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Cadherins / biosynthesis*
  • Female
  • Humans
  • Immunohistochemistry
  • Neoplasm Recurrence, Local / metabolism
  • Neoplasm Recurrence, Local / pathology
  • Phyllodes Tumor / metabolism
  • Phyllodes Tumor / pathology*
  • Prognosis
  • alpha Catenin / biosynthesis*
  • beta Catenin / biosynthesis*

Substances

  • Biomarkers, Tumor
  • CTNNB1 protein, human
  • Cadherins
  • alpha Catenin
  • beta Catenin